Clinical Trials Directory

Trials / Terminated

TerminatedNCT02426489

Improving Diagnosis of Breast Cancer by Using a Combined MRI and Positron Emission Mammography (MRI-PEM) System

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
1 (actual)
Sponsor
Weinberg Medical Physics LLC · Industry
Sex
Female
Age
21 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to assess whether the addition of positron emission mammography will add diagnostic value to magnetic resonance imaging of the breast, in patients with lesions of the breast that are suspicious enough to warrant biopsy, or which have been confirmed as containing cancer cells.

Detailed description

70 eligible subjects will be asked to undergo contrast-enhanced MRI studies of the breast containing the lesion. Subjects will be asked to fast for 6 hours prior to the imaging session. Each subject will be tested for glucose, and if the glucose is not too high, the subject will be injected with a dose of radioactive sugar (fluoro-deoxyglucose) which has been shown in other studies to accumulate in breast cancers. The subject will be asked to sit quietly for 30 minutes and to empty the bladder. The subject will then be asked to be re-examined in the MRI scanner with MRI contrast injection. The examination bed will be moved out of the MRI scanner and detectors of the radioactive sugar will be placed near the breast in order to obtain a positron emission mammogram for a 10-minute period. The subject will then leave the MRI suite.

Conditions

Interventions

TypeNameDescription
DEVICEMRI + PEM imageEffect of positron emission mammography on diagnostic accuracy

Timeline

Start date
2015-07-01
Primary completion
2016-05-08
Completion
2016-05-08
First posted
2015-04-27
Last updated
2021-10-07

Source: ClinicalTrials.gov record NCT02426489. Inclusion in this directory is not an endorsement.